Conversely, CDKN1C expression was reduced in carcinoma samples, particularly FTC, indicating its potential utility in distinguishing FTC from other thyroid pathologies, consistent with its role as a tumor suppressor. This evidence concerns the gene CDKN1C and carcinoma.